Inducing Z-DNA overcomes immune checkpoint blockade resistance  被引量:1

在线阅读下载全文

作  者:Huipeng Jiao Manolis Pasparakis 

机构地区:[1]Institute for Genetics,University of Cologne,Cologne,Germany [2]Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases(CECAD),University of Cologne,Cologne,Germany [3]Center for Molecular Medicine(CMMC),University of Cologne,Cologne,Germany.

出  处:《Cell Research》2022年第10期871-872,共2页细胞研究(英文版)

摘  要:Inducing immunogenic cell death in tumors holds promise in stimulating anti-tumor immunity.A recent study published in Nature reported that a small molecule previously shown to induce the formation of Z-DNA activates ZBP1-dependent cell death and renders tumors sensitive to immune checkpoint blockade-based immunotherapy.Cancer immunotherapy by immune checkpoint blockade(ICB)has achieved remarkable success in individual cases;however,these are still restricted to a small number of patients.Therefore,novel approaches to enhance anti-tumor immunity are urgently needed.Induction of immunogenic cell death,such as necroptosis,in tumor cells was shown to synergize with ICB to induce antitumor immune responses in mouse models.1 The RNA-editing enzyme adenosine deaminase acting on RNA 1(ADAR1)has emerged as a novel checkpoint conferring resistance to ICB therapy.

关 键 词:ADAR1 RESISTANCE RENDER 

分 类 号:Q52[生物学—生物化学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象